Sixth Element Capital LLP (6EC) Overview
Sixth Element Capital LLP (6EC) is a UK-based fund manager established to manage the £70 million CRT Pioneer Fund, dedicated to investments in oncology development programs across Europe. The fund aims to bridge the investment gap between cancer drug discovery and early clinical development, focusing on bringing innovative therapeutic products and technologies to market.
Is Sixth Element Capital LLP (6EC) the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Sixth Element Capital LLP (6EC), along with a list of other relevant VCs, is available on Hopohopo.io.
Sixth Element Capital LLP (6EC)
Investment focus
Invest in
- Western Europe 1 / 14
Product type
- Drugs / Pharma
Industries / verticals
- BioTech & Life Sciences
- PharmaTech
Stages
Series A
First ticket size
£3,000,000 - £3,000,000
How to approach funds like Sixth Element Capital LLP (6EC)
When approaching Sixth Element Capital, founders should highlight the clinical and translational potential of their oncology innovations, especially those with clear pathways to early clinical milestones. Demonstrating robust scientific validation, a strong IP position, and a credible plan for regulatory advancement will resonate. Emphasize collaborations with leading academic or clinical institutions and articulate how your program addresses unmet needs in cancer treatment, as 6EC values projects with tangible impact and a clear route to patient benefit.
Find the best-fitting investors for your startup
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.
